ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMCR Immunocore Holdings PLC

61.91
1.68 (2.79%)
After Hours
Last Updated: 07:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immunocore Holdings PLC IMCR NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
1.68 2.79% 61.91 07:30:00
Open Price Low Price High Price Close Price Previous Close
60.25 59.70 62.74 61.91 60.23
more quote information »

Recent News

Date Time Source Heading
25/4/202400:00GLOBEImmunocore announces upcoming presentation and posters at..
05/4/202407:00GLOBEImmunocore to present at upcoming investor conferences
06/3/202408:30GLOBEImmunocore presented two posters at CROI 2024
01/3/202423:00GLOBEImmunocore to present at upcoming investor conferences
29/2/202408:19EDGAR2Form 8-K - Current report
29/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202423:34GLOBEImmunocore reports fourth quarter and full year 2023..
28/2/202423:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202410:46EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:00GLOBEImmunocore announces clinical trial collaboration and supply..
22/2/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202423:00GLOBEImmunocore to report fourth quarter and full year 2023..
03/2/202408:05EDGAR2Form 8-K - Current report
31/1/202415:30GLOBEImmunocore Prices Upsized Convertible Senior Notes Offering
30/1/202409:06EDGAR2Form 8-K - Current report
30/1/202408:05GLOBEImmunocore Announces Proposed Convertible Senior Notes..
06/1/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:19EDGAR2Form 8-K - Current report
05/1/202423:00GLOBEImmunocore announces strategic priorities and pipeline..
04/1/202409:55EDGAR2Form 144 - Report of proposed sale of securities
03/1/202423:00GLOBEImmunocore to present at the 42nd Annual J.P. Morgan..
03/1/202408:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:25EDGAR2Form 8-K - Current report
28/12/202309:30EDGAR2Form 144 - Report of proposed sale of securities
21/12/202305:54EDGAR2Form 144 - Report of proposed sale of securities
01/12/202312:33EDGAR2Form 144 - Report of proposed sale of securities
30/11/202320:00GLOBELevicept Appoints Eliot Forster as CEO
17/11/202301:51EDGAR2Form 144 - Report of proposed sale of securities
07/11/202323:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202323:00GLOBEImmunocore Reports Third Quarter 2023 Financial Results and..
07/11/202311:20EDGAR2Form 144 - Report of proposed sale of securities
02/11/202307:01GLOBEImmunocore announces upcoming poster presentations at SITC..
31/10/202307:30GLOBEImmunocore to present at upcoming investor conferences
21/10/202323:45GLOBEImmunocore presents three-year overall survival data from..
06/10/202322:01GLOBEImmunocore announces upcoming presentation and posters at..
03/10/202307:31EDGAR2Form 144 - Report of proposed sale of securities
12/9/202307:00GLOBEImmunocore to present at upcoming investor conferences
02/9/202306:00GLOBEImmunocore to present at upcoming investor conferences
26/8/202308:10EDGAR2Form 144 - Report of proposed sale of securities
18/8/202305:44EDGAR2Form 144 - Report of proposed sale of securities
10/8/202322:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202321:00GLOBEImmunocore Reports Second Quarter 2023 Financial Results and..
03/8/202322:00GLOBEImmunocore to report second quarter 2023 financial results..
15/7/202306:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/7/202307:28EDGAR2Form 144 - Report of proposed sale of securities
03/6/202321:00GLOBEImmunocore presents additional ctDNA data from the KIMMTRAK..
02/6/202306:30GLOBEImmunocore to present at upcoming investor conferences

Your Recent History

Delayed Upgrade Clock